Skip to main content

Table 1 Baseline clinicopathologic characteristics of patients who received PIPAC

From: Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal malignancy: initial experience of the first program in the Baltic countries

Malignancy; n (%) Gastric cancer 9 (60.0%)
  Ovarian cancer 6 (40%)
Median PCI score (Q1; Q3); Before PIPAC 8 (4; 15)
After PIPAC 5 (1; 16)
Sex; n (%) Female (n; %) 11 (73.3%)
Male (n; %) 4 (26.7%)
Median age (Q1; Q3); years 58 (51; 68)
Median hospitalization (Q1; Q3); days 5 (3; 6)
Median BMI (Q1; Q3) 25 (20; 30)
History of radical surgery for primary tumor; (n; %) Yes 8 (53.3%)
No 7 (46.7%)
Median CA125 level (Q1; Q3); kIU/l 103 (15; 351)
Median CEA level (Q1; Q3); ng/l 1.4 (0.5; 9.6)
Median CA19.9 level (Q1; Q3); ng/l 12.3 (6.9; 75.9)
Number of PIPAC procedures 1 5 (33.3%)
2 2 (13.3%)
3–4 8 (53.4%)
Median operation time (Q1; Q3); min
minutes
115 (110; 133)